Medtronic To Evaluate Drug-Eluting Stent For Erectile Dysfunction
This article was originally published in The Gray Sheet
With the drug-eluting stent market more sluggish than it used to be, companies are looking for new ways to leverage the vascular technology. Medtronic signaled its interest last week in one such alternative for DES: erectile dysfunction
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.